Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Hendry

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Annals of the Rheumatic Diseases|April 16, 2025
Response to: Correspondence on '2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria' by Yeng et alMedha Barbhaiya, Stephane Zuily, Alison Hendry, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2024
ReplyMedha Barbhaiya, Stephane Zuily, Alison Hendry, et al.
Science Advances|May 18, 2022
First source-to-sink monitoring shows dense head controls sediment flux and runout in turbidity currentsEd L Pope, Matthieu J B Cartigny, Michael A Clare, et al.
Seminars in Arthritis and Rheumatism|April 15, 2026
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritisMedha L Soowamber, Milena Bond, Catalina Sanchez-Alvarez, et al.
Arthritis Care & Research|July 7, 2025
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of DefinitionsMedha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah, et al.
Arthritis Care & Research|August 13, 2024
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision AnalysisMedha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases|August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Annals of the Rheumatic Diseases|April 16, 2025
Response to: Correspondence on '2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria' by Yeng et alMedha Barbhaiya, Stephane Zuily, Alison Hendry, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2024
ReplyMedha Barbhaiya, Stephane Zuily, Alison Hendry, et al.
Science Advances|May 18, 2022
First source-to-sink monitoring shows dense head controls sediment flux and runout in turbidity currentsEd L Pope, Matthieu J B Cartigny, Michael A Clare, et al.
Seminars in Arthritis and Rheumatism|April 15, 2026
A Delphi exercise informing the development of criteria to measure response to treatment in giant cell arteritisMedha L Soowamber, Milena Bond, Catalina Sanchez-Alvarez, et al.
Arthritis Care & Research|July 7, 2025
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of DefinitionsMedha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah, et al.
Arthritis Care & Research|August 13, 2024
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision AnalysisMedha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification CriteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases|August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteriaMedha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Pageof 1